Connect Biopharma Holdings Ltd - ADR Forecast, price target & analysts
Connect Biopharma Holdings Ltd - ADR Target price 2025 - Analyst rating & recommendation
Connect Biopharma Holdings Ltd - ADR Classifications & Recommendation:
Connect Biopharma Holdings Ltd - ADR Price Target
| Target Price | $7.65 |
| Price | $2.73 |
| Potential |
180.22%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Connect Biopharma Holdings Ltd - ADR 2026 .
The average Connect Biopharma Holdings Ltd - ADR target price is $7.65.
This is
180.22%
register free of charge
$10.50
284.62%
register free of charge
$6.06
121.98%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend Connect Biopharma Holdings Ltd - ADR to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Connect Biopharma Holdings Ltd - ADR stock has an average upside potential 2026 of
180.22%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 26.03 | 0.30 |
| 98.85% | ||
| Net Margin | -60.05% | -91,745.01% |
| 152,690.95% |
7 Analysts have issued a sales forecast Connect Biopharma Holdings Ltd - ADR 2025 . The average Connect Biopharma Holdings Ltd - ADR sales estimate is
This results in the following potential growth metrics:
7 Connect Biopharma Holdings Ltd - ADR Analysts have issued a net profit forecast 2025. The average Connect Biopharma Holdings Ltd - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.28 | -4.92 |
| 75.22% | 1,657.14% | |
| P/E | negative | |
| EV/Sales | 327.00 |
7 Analysts have issued a Connect Biopharma Holdings Ltd - ADR forecast for earnings per share. The average Connect Biopharma Holdings Ltd - ADR EPS is
This results in the following potential growth metrics and future valuations:
Connect Biopharma Holdings Ltd - ADR...
Current Connect Biopharma Holdings Ltd - ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Lake Street |
Locked
➜
Locked
|
Locked | Dec 01 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Nov 13 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Oct 31 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 13 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 06 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Lake Street:
Locked
➜
Locked
|
Dec 01 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Nov 13 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Oct 31 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 13 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 01 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 06 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
